Leadless pacemakers may represent a promising alternative for patients with artificial tricuspid valves to minimize the risk of prosthesis damage.
May support leadless pacemakers in tricuspid bioprostheses; hypothesis-generating case leaves need for prospective validation open.
<ns3:p>In case of the need of pacemaker implantation, patients with artificial tricuspid valve are a special group of subjects,because of high risk of dysfunction of the prosthesis. In case of mechanical prosthesis of tricuspid valvethe leads of pacemaker are usually located in coronary sinus. In case of biological prosthesis of tricuspid valvedespite of the risk of prosthesis damage the electrodes are implanted endocardially. The leadless pacemakersseems to be promising alternative in patients with artificial tricuspid valve because of minor risk of valve damage.The case report concerns to the patient with tachycardia-bradycardia syndrome and biological prosthesisof tricuspid valve in whom the leadless pacemaker Micra was implanted.</ns3:p>
No takes yet. Share an insight, caveat, or question.
Kowalska et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: